Company intelligence / Profile preview

Nanosthetic

Ownership: Private
Development stage: Other

Overview

Nanosthetic develops human biologics-based products, including a novel cosmetic, manufactured with proprietary sterile processing to produce endotoxin- and microorganism-free tissues; the focus to date has been R&D and cleanroom/FDA readiness rather than formal clinical trials.[5][7]

Therapeutic areas: OtherRheumatologyDermatology
Modalities: Biologic
Industry: Biotech

Partnerships

Emergent Health subsidiary Evolutionary Biologics (products manufactured by Nanosthetic and sold/marketed by Evolutionary Biologics)[5]

Beyond the preview

Go deeper on Nanosthetic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanosthetic.

Explore the full profile